nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethobenzamide—Coma—Glimepiride—type 2 diabetes mellitus	0.0198	0.0207	CcSEcCtD
Trimethobenzamide—Blood disorder—Gliclazide—type 2 diabetes mellitus	0.0192	0.0201	CcSEcCtD
Trimethobenzamide—Jaundice—Acarbose—type 2 diabetes mellitus	0.0183	0.0192	CcSEcCtD
Trimethobenzamide—Jaundice—Nateglinide—type 2 diabetes mellitus	0.0177	0.0185	CcSEcCtD
Trimethobenzamide—Blood disorder—Orlistat—type 2 diabetes mellitus	0.0174	0.0182	CcSEcCtD
Trimethobenzamide—Blood disorder—Metformin—type 2 diabetes mellitus	0.0161	0.0168	CcSEcCtD
Trimethobenzamide—Jaundice—Repaglinide—type 2 diabetes mellitus	0.0153	0.016	CcSEcCtD
Trimethobenzamide—Coma—Gliclazide—type 2 diabetes mellitus	0.0147	0.0153	CcSEcCtD
Trimethobenzamide—Drowsiness—Glipizide—type 2 diabetes mellitus	0.013	0.0136	CcSEcCtD
Trimethobenzamide—Cramp muscle—Bromocriptine—type 2 diabetes mellitus	0.0128	0.0134	CcSEcCtD
Trimethobenzamide—Jaundice—Glipizide—type 2 diabetes mellitus	0.0127	0.0132	CcSEcCtD
Trimethobenzamide—Drowsiness—Glimepiride—type 2 diabetes mellitus	0.0121	0.0127	CcSEcCtD
Trimethobenzamide—Jaundice—Glimepiride—type 2 diabetes mellitus	0.0118	0.0123	CcSEcCtD
Trimethobenzamide—Drowsiness—Bromocriptine—type 2 diabetes mellitus	0.0109	0.0114	CcSEcCtD
Trimethobenzamide—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.0104	0.0109	CcSEcCtD
Trimethobenzamide—Muscle spasms—Glipizide—type 2 diabetes mellitus	0.00976	0.0102	CcSEcCtD
Trimethobenzamide—Jaundice—Glyburide—type 2 diabetes mellitus	0.00975	0.0102	CcSEcCtD
Trimethobenzamide—Cramp muscle—Valsartan—type 2 diabetes mellitus	0.00964	0.0101	CcSEcCtD
Trimethobenzamide—Vision blurred—Glipizide—type 2 diabetes mellitus	0.00957	0.01	CcSEcCtD
Trimethobenzamide—Cramp muscle—Orlistat—type 2 diabetes mellitus	0.00953	0.00995	CcSEcCtD
Trimethobenzamide—Muscle spasms—Pioglitazone—type 2 diabetes mellitus	0.00935	0.00977	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00911	0.00951	CcSEcCtD
Trimethobenzamide—Muscle spasms—Sitagliptin—type 2 diabetes mellitus	0.00908	0.00949	CcSEcCtD
Trimethobenzamide—Drowsiness—Gliclazide—type 2 diabetes mellitus	0.00898	0.00938	CcSEcCtD
Trimethobenzamide—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.00893	0.00933	CcSEcCtD
Trimethobenzamide—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.0089	0.0093	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00884	0.00924	CcSEcCtD
Trimethobenzamide—Cramp muscle—Metformin—type 2 diabetes mellitus	0.00878	0.00917	CcSEcCtD
Trimethobenzamide—Jaundice—Gliclazide—type 2 diabetes mellitus	0.00875	0.00914	CcSEcCtD
Trimethobenzamide—Headache—Tolbutamide—type 2 diabetes mellitus	0.0086	0.00898	CcSEcCtD
Trimethobenzamide—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.00855	0.00893	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00853	0.00891	CcSEcCtD
Trimethobenzamide—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.00846	0.00884	CcSEcCtD
Trimethobenzamide—Cramp muscle—Irbesartan—type 2 diabetes mellitus	0.00829	0.00865	CcSEcCtD
Trimethobenzamide—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00826	0.00863	CcSEcCtD
Trimethobenzamide—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00826	0.00863	CcSEcCtD
Trimethobenzamide—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.00822	0.00858	CcSEcCtD
Trimethobenzamide—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.00821	0.00858	CcSEcCtD
Trimethobenzamide—Convulsion—Glimepiride—type 2 diabetes mellitus	0.00821	0.00858	CcSEcCtD
Trimethobenzamide—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00806	0.00842	CcSEcCtD
Trimethobenzamide—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.00792	0.00827	CcSEcCtD
Trimethobenzamide—Headache—Tolazamide—type 2 diabetes mellitus	0.00783	0.00817	CcSEcCtD
Trimethobenzamide—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00783	0.00817	CcSEcCtD
Trimethobenzamide—Cramp muscle—Losartan—type 2 diabetes mellitus	0.0078	0.00814	CcSEcCtD
Trimethobenzamide—Headache—Linagliptin—type 2 diabetes mellitus	0.00775	0.00809	CcSEcCtD
Trimethobenzamide—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00765	0.00799	CcSEcCtD
Trimethobenzamide—Verapamil—KCNJ11—type 2 diabetes mellitus	0.0076	0.179	CrCbGaD
Trimethobenzamide—Drowsiness—Metformin—type 2 diabetes mellitus	0.00751	0.00785	CcSEcCtD
Trimethobenzamide—Convulsion—Bromocriptine—type 2 diabetes mellitus	0.00741	0.00774	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00738	0.00771	CcSEcCtD
Trimethobenzamide—Somnolence—Glipizide—type 2 diabetes mellitus	0.00737	0.0077	CcSEcCtD
Trimethobenzamide—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00737	0.00769	CcSEcCtD
Trimethobenzamide—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00723	0.00755	CcSEcCtD
Trimethobenzamide—Jaundice—Irbesartan—type 2 diabetes mellitus	0.00691	0.00722	CcSEcCtD
Trimethobenzamide—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00688	0.00718	CcSEcCtD
Trimethobenzamide—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00685	0.00716	CcSEcCtD
Trimethobenzamide—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00685	0.00716	CcSEcCtD
Trimethobenzamide—Convulsion—Glyburide—type 2 diabetes mellitus	0.00677	0.00707	CcSEcCtD
Trimethobenzamide—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.00669	0.00698	CcSEcCtD
Trimethobenzamide—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00652	0.00681	CcSEcCtD
Trimethobenzamide—Jaundice—Losartan—type 2 diabetes mellitus	0.0065	0.00679	CcSEcCtD
Trimethobenzamide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00648	0.00677	CcSEcCtD
Trimethobenzamide—Colchicine—CYP2E1—type 2 diabetes mellitus	0.00644	0.151	CrCbGaD
Trimethobenzamide—Headache—Repaglinide—type 2 diabetes mellitus	0.00628	0.00655	CcSEcCtD
Trimethobenzamide—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00626	0.00654	CcSEcCtD
Trimethobenzamide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.0062	0.00648	CcSEcCtD
Trimethobenzamide—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.0062	0.00647	CcSEcCtD
Trimethobenzamide—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.00613	0.0064	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00611	0.00638	CcSEcCtD
Trimethobenzamide—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00608	0.00635	CcSEcCtD
Trimethobenzamide—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00608	0.00635	CcSEcCtD
Trimethobenzamide—Vision blurred—Orlistat—type 2 diabetes mellitus	0.006	0.00627	CcSEcCtD
Trimethobenzamide—Hypotension—Glyburide—type 2 diabetes mellitus	0.00596	0.00623	CcSEcCtD
Trimethobenzamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00593	0.00619	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00585	0.00611	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.0057	0.00595	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00568	0.00593	CcSEcCtD
Trimethobenzamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00567	0.00592	CcSEcCtD
Trimethobenzamide—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00565	0.0059	CcSEcCtD
Trimethobenzamide—Jaundice—Ramipril—type 2 diabetes mellitus	0.00558	0.00583	CcSEcCtD
Trimethobenzamide—Vision blurred—Metformin—type 2 diabetes mellitus	0.00553	0.00578	CcSEcCtD
Trimethobenzamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.00552	0.00577	CcSEcCtD
Trimethobenzamide—Dizziness—Glipizide—type 2 diabetes mellitus	0.00548	0.00572	CcSEcCtD
Trimethobenzamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00543	0.00567	CcSEcCtD
Trimethobenzamide—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00535	0.00559	CcSEcCtD
Trimethobenzamide—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.00533	0.00556	CcSEcCtD
Trimethobenzamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00529	0.00553	CcSEcCtD
Trimethobenzamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00528	0.00551	CcSEcCtD
Trimethobenzamide—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00525	0.00548	CcSEcCtD
Trimethobenzamide—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00522	0.00545	CcSEcCtD
Trimethobenzamide—Headache—Glipizide—type 2 diabetes mellitus	0.00519	0.00542	CcSEcCtD
Trimethobenzamide—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00511	0.00534	CcSEcCtD
Trimethobenzamide—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.0051	0.00532	CcSEcCtD
Trimethobenzamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00509	0.00532	CcSEcCtD
Trimethobenzamide—Cisapride—HTR2C—type 2 diabetes mellitus	0.00505	0.119	CrCbGaD
Trimethobenzamide—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00501	0.00524	CcSEcCtD
Trimethobenzamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.00497	0.0052	CcSEcCtD
Trimethobenzamide—Hypotension—Valsartan—type 2 diabetes mellitus	0.00492	0.00514	CcSEcCtD
Trimethobenzamide—Vision blurred—Losartan—type 2 diabetes mellitus	0.00491	0.00513	CcSEcCtD
Trimethobenzamide—Headache—Glimepiride—type 2 diabetes mellitus	0.00485	0.00506	CcSEcCtD
Trimethobenzamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.00483	0.00504	CcSEcCtD
Trimethobenzamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00477	0.00499	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0047	0.00491	CcSEcCtD
Trimethobenzamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.00468	0.00489	CcSEcCtD
Trimethobenzamide—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00461	0.00482	CcSEcCtD
Trimethobenzamide—Hypotension—Metformin—type 2 diabetes mellitus	0.00448	0.00468	CcSEcCtD
Trimethobenzamide—Trimethoprim—CYP3A4—type 2 diabetes mellitus	0.00439	0.103	CrCbGaD
Trimethobenzamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.00437	0.00457	CcSEcCtD
Trimethobenzamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00436	0.00456	CcSEcCtD
Trimethobenzamide—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.0043	0.00449	CcSEcCtD
Trimethobenzamide—Somnolence—Metformin—type 2 diabetes mellitus	0.00426	0.00445	CcSEcCtD
Trimethobenzamide—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00423	0.00441	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00422	0.00441	CcSEcCtD
Trimethobenzamide—Verapamil—ABCC2—type 2 diabetes mellitus	0.00411	0.0966	CrCbGaD
Trimethobenzamide—Colchicine—CYP3A4—type 2 diabetes mellitus	0.00406	0.0953	CrCbGaD
Trimethobenzamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00402	0.0042	CcSEcCtD
Trimethobenzamide—Headache—Glyburide—type 2 diabetes mellitus	0.004	0.00417	CcSEcCtD
Trimethobenzamide—Hypotension—Losartan—type 2 diabetes mellitus	0.00398	0.00415	CcSEcCtD
Trimethobenzamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00392	0.00409	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00388	0.00405	CcSEcCtD
Trimethobenzamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.00387	0.00405	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00383	0.004	CcSEcCtD
Trimethobenzamide—Cisapride—CYP1A2—type 2 diabetes mellitus	0.00381	0.0896	CrCbGaD
Trimethobenzamide—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00379	0.00396	CcSEcCtD
Trimethobenzamide—Somnolence—Losartan—type 2 diabetes mellitus	0.00378	0.00395	CcSEcCtD
Trimethobenzamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.0036	0.00376	CcSEcCtD
Trimethobenzamide—Headache—Gliclazide—type 2 diabetes mellitus	0.00359	0.00375	CcSEcCtD
Trimethobenzamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00356	0.00372	CcSEcCtD
Trimethobenzamide—Dizziness—Valsartan—type 2 diabetes mellitus	0.00348	0.00363	CcSEcCtD
Trimethobenzamide—Dizziness—Orlistat—type 2 diabetes mellitus	0.00344	0.00359	CcSEcCtD
Trimethobenzamide—Hypotension—Ramipril—type 2 diabetes mellitus	0.00341	0.00356	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00333	0.00348	CcSEcCtD
Trimethobenzamide—Headache—Valsartan—type 2 diabetes mellitus	0.0033	0.00344	CcSEcCtD
Trimethobenzamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00328	0.00342	CcSEcCtD
Trimethobenzamide—Headache—Orlistat—type 2 diabetes mellitus	0.00326	0.0034	CcSEcCtD
Trimethobenzamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.00324	0.00339	CcSEcCtD
Trimethobenzamide—Dizziness—Metformin—type 2 diabetes mellitus	0.00317	0.00331	CcSEcCtD
Trimethobenzamide—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00314	0.00327	CcSEcCtD
Trimethobenzamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00309	0.00323	CcSEcCtD
Trimethobenzamide—Headache—Metformin—type 2 diabetes mellitus	0.003	0.00314	CcSEcCtD
Trimethobenzamide—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00299	0.00312	CcSEcCtD
Trimethobenzamide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00291	0.00304	CcSEcCtD
Trimethobenzamide—Headache—Irbesartan—type 2 diabetes mellitus	0.00283	0.00296	CcSEcCtD
Trimethobenzamide—Dizziness—Losartan—type 2 diabetes mellitus	0.00281	0.00294	CcSEcCtD
Trimethobenzamide—Verapamil—CYP1A2—type 2 diabetes mellitus	0.00274	0.0645	CrCbGaD
Trimethobenzamide—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00269	0.00281	CcSEcCtD
Trimethobenzamide—Headache—Losartan—type 2 diabetes mellitus	0.00267	0.00278	CcSEcCtD
Trimethobenzamide—Cisapride—CYP3A4—type 2 diabetes mellitus	0.00252	0.0593	CrCbGaD
Trimethobenzamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.0025	0.00261	CcSEcCtD
Trimethobenzamide—Dizziness—Ramipril—type 2 diabetes mellitus	0.00241	0.00252	CcSEcCtD
Trimethobenzamide—Headache—Ramipril—type 2 diabetes mellitus	0.00229	0.00239	CcSEcCtD
Trimethobenzamide—Verapamil—CYP3A4—type 2 diabetes mellitus	0.00182	0.0427	CrCbGaD
